News

GSK PLC closed 14.69% below its 52-week high of £17.67, which the company reached on May 31st.
Shares have added about 3.2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Glaxo due for a pullback? Before we ...
This Abrysvo or Arexvy market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the ...
GSK PLC closed 18.99% short of its 52-week high of £17.88, which the company achieved on May 28th.